Abstract
Long-term efficacy of a new, fixed, very-low-dose angiotension converting enzyme inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
